A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/11396219

Download in:

View as

General Info

PMID
11396219